Correlation Between Zaptec AS and Vicore Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zaptec AS and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zaptec AS and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zaptec AS and Vicore Pharma Holding, you can compare the effects of market volatilities on Zaptec AS and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zaptec AS with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zaptec AS and Vicore Pharma.

Diversification Opportunities for Zaptec AS and Vicore Pharma

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Zaptec and Vicore is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Zaptec AS and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Zaptec AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zaptec AS are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Zaptec AS i.e., Zaptec AS and Vicore Pharma go up and down completely randomly.

Pair Corralation between Zaptec AS and Vicore Pharma

Assuming the 90 days trading horizon Zaptec AS is expected to under-perform the Vicore Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Zaptec AS is 1.11 times less risky than Vicore Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The Vicore Pharma Holding is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  2,325  in Vicore Pharma Holding on August 25, 2024 and sell it today you would lose (1,534) from holding Vicore Pharma Holding or give up 65.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.8%
ValuesDaily Returns

Zaptec AS  vs.  Vicore Pharma Holding

 Performance 
       Timeline  
Zaptec AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zaptec AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Vicore Pharma Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vicore Pharma Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Zaptec AS and Vicore Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zaptec AS and Vicore Pharma

The main advantage of trading using opposite Zaptec AS and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zaptec AS position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.
The idea behind Zaptec AS and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals